West Paces Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $281K | Buy |
2,222
+53
| +2% | +$6.98K | 0.05% | 139 |
|
|
2026
Q1 | $302K | Hold |
2,169
| – | – | 0.06% | 125 |
|
|
2025
Q4 | $266K | Buy |
2,169
+152
| +8% | +$18.5K | 0.05% | 138 |
|
|
2025
Q3 | $224K | Hold |
2,017
| – | – | 0.04% | 142 |
|
|
2025
Q2 | $224K | Sell |
2,017
-230
| -10% | -$24.5K | 0.05% | 141 |
|
|
2025
Q1 | $252K | Hold |
2,247
| – | – | 0.06% | 120 |
|
|
2024
Q4 | $208K | Hold |
2,247
| – | – | 0.05% | 128 |
|
|
2024
Q3 | $188K | Hold |
2,247
| – | – | 0.05% | 141 |
|
|
2024
Q2 | $154K | Hold |
2,247
| – | – | 0.04% | 144 |
|
|
2024
Q1 | $165K | Sell |
2,247
-15
| -0.7% | -$1.15K | 0.04% | 144 |
|
|
2023
Q4 | $183K | Buy |
2,262
+15
| +0.7% | +$1.17K | 0.05% | 124 |
|
|
2023
Q3 | $168K | Hold |
2,247
| – | – | 0.05% | 126 |
|
|
2023
Q2 | $173K | Hold |
2,247
| – | – | 0.05% | 130 |
|
|
2023
Q1 | $186K | Buy |
2,247
+35
| +2% | +$2.9K | 0.06% | 122 |
|
|
2022
Q4 | $190K | Hold |
2,212
| – | – | 0.06% | 123 |
|
|
2022
Q3 | $136K | Hold |
2,212
| – | – | 0.05% | 140 |
|
|
2022
Q2 | $137K | Hold |
2,212
| – | – | 0.05% | 143 |
|
|
2022
Q1 | $132K | Hold |
2,212
| – | – | 0.04% | 148 |
|
|
2021
Q4 | $161K | Buy |
2,212
+1,152
| +109% | +$79.3K | 0.05% | 131 |
|
|
2021
Q3 | $74K | Hold |
1,060
| – | – | 0.03% | 187 |
|
|
2021
Q2 | $73K | Hold |
1,060
| – | – | 0.03% | 176 |
|
|
2021
Q1 | $68.5K | Hold |
1,060
| – | – | 0.03% | 167 |
|
|
2020
Q4 | $61.8K | Hold |
1,060
| – | – | 0.03% | 169 |
|
|
2020
Q3 | $67K | Hold |
1,060
| – | – | 0.03% | 154 |
|
|
2020
Q2 | $81.6K | Hold |
1,060
| – | – | 0.04% | 147 |
|
|
2020
Q1 | $79.2K | Sell |
1,060
-133
| -11% | -$9.19K | 0.05% | 142 |
|
|
2019
Q4 | $77.5K | Hold |
1,193
| – | – | 0.04% | 158 |
|
|
2019
Q3 | $75.6K | Hold |
1,193
| – | – | 0.05% | 152 |
|
|
2019
Q2 | $80.6K | Hold |
1,193
| – | – | 0.05% | 142 |
|
|
2019
Q1 | $77.6K | Sell |
1,193
-30
| -2% | -$1.99K | 0.05% | 145 |
|
|
2018
Q4 | $76.5K | Hold |
1,223
| – | – | 0.06% | 142 |
|
|
2018
Q3 | $94.4K | Hold |
1,223
| – | – | 0.07% | 136 |
|
|
2018
Q2 | $86.6K | Buy |
1,223
+30
| +3% | +$2.12K | 0.06% | 136 |
|
|
2018
Q1 | $89.9K | Hold |
1,193
| – | – | 0.07% | 131 |
|
|
2017
Q4 | $85.5K | Sell |
1,193
-155
| -11% | -$11.8K | 0.06% | 145 |
|
|
2017
Q3 | $109K | Buy |
1,348
+74
| +6% | +$5.66K | 0.08% | 136 |
|
|
2017
Q2 | $90.2K | Sell |
1,274
-163
| -11% | -$10.8K | 0.07% | 140 |
|
|
2017
Q1 | $97.6K | Sell |
1,437
-1,081
| -43% | -$76K | 0.08% | 135 |
|
|
2016
Q4 | $180K | Buy |
+2,518
| New | +$187K | 0.17% | 110 |
|
Other funds holding GILD
West Paces Advisors's GILD Position: Q2 2026 in Review
West Paces Advisors increased its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, buying an estimated $6.98K and bringing the position to 2,222 shares worth $281K. The position accounts for 0.05% of the portfolio, ranked #139.
West Paces Advisors first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $302K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- West Paces Advisors held 2,222 shares of Gilead Sciences worth $281K as of Q2 2026.
- West Paces Advisors bought 53 Gilead Sciences shares in Q2 2026, an estimated $6.98K.
- Gilead Sciences made up 0.05% of West Paces Advisors's portfolio in Q2 2026, its #139 holding.
- West Paces Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
- West Paces Advisors's Gilead Sciences position peaked at $302K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.